Federal Register / Vol. 62, No. 220 / Friday, November 14, 1997 / Rules and Regulations 61011

SUMMARY: This document makes a

correction to Airworthiness Directive

(AD) 97–19–13 applicable to Pratt &

Whitney (PW) JT8D–200 series turbofan

engines that was published in the

Federal Register on September 19, 1997

(62 FR 49135). The paragraph references

to the Accomplishment Instructions of

PW Alert Service Bulletin (ASB) No.

5944, Revision 3, dated December 16,

1994, in paragraph (a)(3) of the

compliance section are incorrect. This

document corrects the paragraph

references. In all other respects, the

original document remains the same.

EFFECTIVE DATE: November 14, 1997.

FOR FURTHER INFORMATION CONTACT:

Christopher Spinney, Aerospace

Engineer, Engine Certification Office,

FAA, Engine and Propeller Directorate,

12 New England Executive Park,

Burlington, MA 01803–5299; telephone

(781) 238–7175, fax (781) 238–7199.

SUPPLEMENTARY INFORMATION: A final

rule airworthiness directive applicable

to Pratt & Whitney (PW) JT8D–200

series turbofan engines, was published

in the Federal Register on September

19, 1997 (62 FR 49135). The following

correction is needed:

§ 39.13 [Corrected]

On page 49136, in the third column,

in the Compliance Section, in paragraph

(a)(3), in the sixth line, ‘‘2.A.(2) (c) and

(d) or (f) and (g)’’ is corrected to read

‘‘2.A.(2) (a) and (b) or (d) and (e)’’.

Issued in Burlington, MA, on November 6,

1997.

Jay J. Pardee,

Manager, Engine and Propeller Directorate,

Aircraft Certification Service.

[FR Doc. 97–29968 Filed 11–13–97; 8:45 am]

BILLING CODE 4910–13–U

DEPARTMENT OF HEALTH AND

HUMAN SERVICES

Food and Drug Administration

21 CFR Part 558

New Animal Drugs For Use In Animal

Feeds; Carbarsone and Bacitracin Zinc

AGENCY: Food and Drug Administration,

HHS.

ACTION: Final rule.

SUMMARY: The Food and Drug

Administration (FDA) is amending the

animal drug regulations to reflect

approval of an abbreviated new animal

drug application (ANADA) filed by

Alpharma Inc. The ANADA provides for

using approved carbarsone and

bacitracin zinc Type A medicated

articles to make Type C medicated

turkey feeds used for prevention of

blackhead, increased rate of weight gain,

and improved feed efficiency.

EFFECTIVE DATE: November 14, 1997.

FOR FURTHER INFORMATION CONTACT:

Jeffrey M. Gilbert, Center for Veterinary

Medicine (HFV–128), Food and Drug

Administration, 7500 Standish Pl.,

Rockville, MD 20855, 301–594–1602.

SUPPLEMENTARY INFORMATION: Alpharma

Inc., One Executive Dr., P.O. Box 1399,

Fort Lee, NJ 07024, is sponsor of

ANADA 200–203 that provides for

combining approved carbarsone and

bacitracin zinc Type A medicated

articles to make Type C medicated feeds

for turkeys containing carbarsone 227 to

340.5 grams per ton (g/t) and bacitracin

zinc 4 to 45 g/t. The Type C medicated

feed is used as an aid in the prevention

of blackhead, for increased rate of

weight gain, and improved feed

efficiency. Alpharma Inc.’s, ANADA 200–203 is

approved as a generic copy of

Hoffmann-LaRoche’s NADA 136–484.

The ANADA is approved as of

November 14, 1997, and the regulations

are amended in § 558.120 (21 CFR

558.120) to reflect the approval. The

basis for approval is discussed in the

freedom of information summary. In addition, § 558.120 is revised by

redesignating paragraph (c) as (d), by

reserving paragraph (c), and newly

redesignated paragraph (d)(1)(iii)(b) is

amended to reflect the approval. In accordance with the freedom of

information provisions of 21 CFR part

20 and 514.11(e)(2)(ii), a summary of

safety and effectiveness data and

information submitted to support

approval of this application may be seen

in the Dockets Management Branch

(HFA–305), Food and Drug

Administration, 12420 Parklawn Dr.,

rm. 1–23, Rockville, MD 20857, between

9 a.m. and 4 p.m., Monday through

Friday. The agency has determined under 21

CFR 25.33(a)(1) that this action is of a

type that does not individually or

cumulatively have a significant effect on

the human environment. Therefore,

neither an environmental assessment

nor an environmental impact statement

is required.

List of Subjects in 21 CFR Part 558

Animal drugs, Animal feeds.

Therefore, under the Federal Food,

Drug, and Cosmetic Act and under

authority delegated to the Commissioner

of Food and Drugs and redelegated to

the Center for Veterinary Medicine, 21

CFR part 558 is amended as follows:

PART 558—NEW ANIMAL DRUGS FOR

USE IN ANIMAL FEEDS

1. The authority citation for 21 CFR

part 558 continues to read as follows:

Authority: 21 U.S.C. 360b, 371.

§ 558.120 [Amended]

2. Section 558.120 Carbarsone (not

U.S.P.) is amended by redesignating

paragraph (c) as paragraph (d), by

reserving paragraph (c), and in newly

redesignated paragraph (d)(1)(iii)(b) by

removing ‘‘No. 000004’’ and adding in

its place ‘‘Nos. 000004 and 046573’’.

Dated: October 22, 1997.

Stephen F. Sundlof,

Director, Center for Veterinary Medicine.

[FR Doc. 97–30033 Filed 11–13–97; 8:45 am]

BILLING CODE 4160–01–F

OCCUPATIONAL SAFETY AND

HEALTH REVIEW COMMISSION

29 CFR Part 2200

Rules of Procedure for E–Z Trials

AGENCY: Occupational Safety and Health

Review Commission.

ACTION: Final rule; correcting

amendment.

SUMMARY: This document restores the

selection provision for commencing E–

Z Trial, 29 CFR 2200.203(a), which was

inadvertently removed.

DATES: November 14, 1997.

FOR FURTHER INFORMATION CONTACT:

Earl R. Ohman, Jr., General Counsel,

(202) 606–5410, Occupational Safety

and Health Review Commission, 1120

20th Street NW., 9th Floor, Washington,

DC 20036–3419.

SUPPLEMENTARY INFORMATION: On

October 30, 1997, (62 FR 58650),

paragraph (a) of § 2200.203 was

inadvertently removed. In order for the

Rules of Procedures for E–Z trial to

operate effectively, paragraph (a) must

be restored.

List of Subjects in 29 CFR Part 2200

Administrative practice and

procedure, Hearing and appeal

procedures.

For the reasons set forth in the

preamble, the Occupational Safety and

Health Review Commission amends

Title 29, Chapter XX, Part 2200, Subpart

M of the Code of Federal Regulations as

follows:

PART 2200—RULES OF PROCEDURE

1. The authority citation continues to

read as follows:

Authority: 29 U.S.C. 661(g).

2. Section 2200.203 is amended by

adding paragraph (a), to read as follow:
61012 Federal Register / Vol. 62, No. 220 / Friday, November 14, 1997 / Rules and Regulations

§ 2200.203 Commencing E–Z Trial.

(a) Selection. Upon receipt of a Notice

of Contest, the Chief Administrative

Law Judge may, at his or her discretion,

assign an appropriate case for E–Z Trial.

* * * * *

Dated: November 7, 1997.

Earl R. Ohman, Jr.,

General Counsel.

[FR Doc. 97–29956 Filed 11–13–97; 8:45 am]

BILLING CODE 7600–01–M

PENSION BENEFIT GUARANTY

CORPORATION

29 CFR Part 4044

Allocation of Assets in SingleEmployer Plans; Interest Assumptions

for Valuing Benefits

AGENCY: Pension Benefit Guaranty

Corporation.

ACTION: Final rule.

SUMMARY: The Pension Benefit Guaranty

Corporation’s regulation on Allocation

of Assets in Single-Employer Plans

prescribes interest assumptions for

valuing benefits under terminating

single-employer plans. This final rule

amends the regulation to adopt interest

assumptions for plans with valuation

dates in December 1997.

EFFECTIVE DATE: December 1, 1997.

FOR FURTHER INFORMATION CONTACT:

Harold J. Ashner, Assistant General

Counsel, Office of the General Counsel,

Pension Benefit Guaranty Corporation,

1200 K Street, NW., Washington, DC

20005, 202–326–4024. (For TTY and

TDD, call 800–877–8339 and request

connection to 202–326–4024).

SUPPLEMENTARY INFORMATION: The

PBGC’s regulation on Allocation of

Assets in Single-Employer Plans (29

CFR part 4044) prescribes actuarial

assumptions for valuing plan benefits of

terminating single-employer plans

covered by title IV of the Employee

Retirement Income Security Act of 1974.

Among the actuarial assumptions

prescribed in part 4044 are interest

assumptions. These interest

assumptions are intended to reflect

current conditions in the financial and

annuity markets.

Two sets of interest assumptions are

prescribed, one set for the valuation of

benefits to be paid as annuities and one

set for the valuation of benefits to be

paid as lump sums. This amendment

adds to appendix B to part 4044 the

annuity and lump sum interest

assumptions for valuing benefits in

plans with valuation dates during

December 1997.

For annuity benefits, the interest

assumptions will be 5.60 percent for the

first 25 years following the valuation

date and 5.00 percent thereafter. The

annuity interest assumptions represent a

decrease (from those in effect for

November 1997) of 0.10 percent for the

first 25 years following the valuation

date and are otherwise unchanged. For

benefits to be paid as lump sums, the

interest assumptions to be used by the

PBGC will be 4.50 percent for the period

during which a benefit is in pay status

and 4.00 percent during any years

preceding the benefit’s placement in pay

status. The lump sum interest

assumptions are unchanged from those

in effect for November 1997.

The PBGC has determined that notice

and public comment on this amendment

are impracticable and contrary to the

public interest. This finding is based on

the need to determine and issue new

interest assumptions promptly so that

the assumptions can reflect, as

accurately as possible, current market

conditions.

Because of the need to provide

immediate guidance for the valuation of

benefits in plans with valuation dates

during December 1997, the PBGC finds

that good cause exists for making the

assumptions set forth in this

amendment effective less than 30 days

after publication.

The PBGC has determined that this

action is not a ‘‘significant regulatory

action’’ under the criteria set forth in

Executive Order 12866.

Because no general notice of proposed

rulemaking is required for this

amendment, the Regulatory Flexibility

Act of 1980 does not apply. See 5 U.S.C.

601(2).

List of Subjects in 29 CFR Part 4044

Pension insurance, Pensions.

In consideration of the foregoing, 29

CFR part 4044 is amended as follows:

PART 4044—ALLOCATION OF

ASSETS IN SINGLE-EMPLOYER

PLANS

1. The authority citation for part 4044

continues to read as follows:

Authority: 29 U.S.C. 1301(a), 1302(b)(3),

1341, 1344, 1362.

2. In appendix B, a new entry is

added to Table I, and Rate Set 50 is

added to Table II, as set forth below.

The introductory text of each table is

republished for the convenience of the

reader and remains unchanged.

Appendix B to Part 4044—Interest Rates Used to Value Annuities and Lump Sums

Table I.—Annuity Valuations

[This table sets forth, for each indicated calendar month, the interest rates (denoted by i1, i2, * * *, and referred to generally

as it) assumed to be in effect between specified anniversaries of a valuation date that occurs within that calendar month; those

anniversaries are specified in the columns adjacent to the rates. The last listed rate is assumed to be in effect after the last listed

anniversary date.]

For valuation dates occurring in the month—

The values of it are:

it for t = it for t = it for t =

* * * * * * *

December 1997 ................................................................. .0560 1–25 .0500 >25 N/A N/A

Table II.—Lump Sum Valuations

[In using this table: (1) For benefits for which the participant or beneficiary is entitled to be in pay status on the valuation

date, the immediate annuity rate shall apply; (2) For benefits for which the deferral period is y years (where y is an integer and

0 < y ≤ n1), interest rate i1 shall apply from the valuation date for a period of y years, and thereafter the immediate annuity rate

shall apply; (3) For benefits for which the deferral period is y years (where y is an integer and n1 < y ≤ n1 + n2), interest rate

i2 shall apply from the valuation date for a period of y – n1 years, interest rate i1 shall apply for the following n1 years, and

thereafter the immediate annuity rate shall apply; (4) For benefits for which the deferral period is y years (where y is an integer

and y > n1 + n2), interest rate i3 shall apply from the valuation date for a period of y – n1 – n2 years, interest rate i2 shall